Advertisement
Advertisement
WVE
Wave Life Sciences Ltd. Ordinary Shares
13.61
USDSponsored
-0.47
-3.32%
Mar 12, 09:40 UTC -4
Open
WVE Earnings Reports
Positive Surprise Ratio
WVE beat 9 of 41 last estimates.
22%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$10.11M
/-$0.33
Implied change from Q4 25 (Revenue/ EPS)
-41.34%
/+10.00%
Implied change from Q1 25 (Revenue/ EPS)
+10.24%
/+17.86%
Wave Life Sciences Ltd. Ordinary Shares earnings per share and revenue
On Feb 26, 2026, WVE reported earnings of -0.30 USD per share (EPS) for Q4 25, missing the estimate of -0.27 USD, resulting in a -9.97% surprise. Revenue reached 17.24 million, compared to an expected 16.46 million, with a 4.76% difference. The market reacted with a +5.64% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 12 analysts forecast an EPS of -0.33 USD, with revenue projected to reach 10.11 million USD, implying an increase of 10.00% EPS, and decrease of -41.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Legend Biotech Corporation - ADR
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.11
Actual
-$0.08
Surprise
+27.73%
BioNTech SE - ADR
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.32
Surprise
-72.12%
enGene Holdings Inc. Common Stock
Report Date
Mar 09, 2026 For Q1 26
Estimate
-$0.57
Actual
-$0.44
Surprise
+22.94%
Design Therapeutics, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.27
Surprise
+25.23%
ADC Therapeutics SA
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.04
Surprise
+85.39%
Kamada Ltd
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.07
Actual
$0.06
Surprise
-24.15%
Whitehawk Therapeutics, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.34
Surprise
-116.42%
Codexis, Inc.
Report Date
Mar 11, 2026 For Q4 25
Estimate
-$0.04
Actual
$0.11
Surprise
+357.01%
Spruce Biosciences, Inc. Common Stock
Report Date
Apr 13, 2026 For Q4 25
Estimate
-$8.14
Actual
-Surprise
-
Elutia Inc. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.14
Surprise
+1.96%
FAQ
What were Wave Life Sciences Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Wave Life Sciences Ltd. Ordinary Shares reported EPS of -$0.30, missing estimates by -9.97%, and revenue of $17.24M, 4.76% above expectations.
How did the market react to Wave Life Sciences Ltd. Ordinary Shares's Q4 2025 earnings?
The stock price moved up 5.64%, changed from $14.54 before the earnings release to $15.36 the day after.
When is Wave Life Sciences Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Wave Life Sciences Ltd. Ordinary Shares's next earnings report?
Based on 12
analysts, Wave Life Sciences Ltd. Ordinary Shares is expected to report EPS of -$0.33 and revenue of $10.11M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement